Pliant Therapeutics, Inc. (PLRX)

NASDAQ: PLRX · IEX Real-Time Price · USD

11.82

-0.27 (-2.23%)

At close: Apr 30, 2024, 4:00 PM

12.06

+0.24 (2.03%)

After-hours: Apr 30, 2024, 6:23 PM EDT

Pliant Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	713	1,085	943	487	806
Market Cap Growth	-	15.09%	93.72%	-39.64%	-
Enterprise Value	229	600	627	293	529
PE Ratio	-6.72	-6.72	-7.64	-5.00	-19.41
PS Ratio	451.24	686.53	97.32	64.25	19.28
PB Ratio	1.51	2.29	3.01	2.44	2.85
P/FCF Ratio	-9.25	-9.25	-9.78	-6.29	-20.77
P/OCF Ratio	-9.32	-9.32	-9.96	-6.45	-21.63
EV/Sales Ratio	144.69	379.98	64.75	38.71	12.66
EV/EBITDA Ratio	-3.85	-3.85	-5.28	-3.12	-13.16
EV/EBIT Ratio	-3.75	-3.75	-5.12	-3.01	-12.74
EV/FCF Ratio	-5.12	-5.12	-6.51	-3.79	-13.64
Debt / Equity Ratio	0.02	0.02	0.05	0.04	-
Debt / EBITDA Ratio	-0.07	-0.07	-0.13	-0.08	-
Debt / FCF Ratio	-0.10	-0.10	-0.16	-0.09	-
Quick Ratio	17.38	17.38	13.93	12.04	24.67
Current Ratio	17.72	17.72	14.23	12.44	25.07
Asset Turnover	0.00	0.00	0.04	0.03	0.15
Interest Coverage	-126.34	-126.34	-154.91	-	-
Return on Equity (ROE)	-31.20%	-31.20%	-50.80%	-41.90%	-19.90%
Return on Assets (ROA)	-29.00%	-29.00%	-44.50%	-39.40%	-14.80%
Return on Capital (ROIC)	-37.97%	-37.97%	-38.64%	-47.29%	-14.71%
Earnings Yield	-22.63%	-14.87%	-13.08%	-19.99%	-5.15%
FCF Yield	-16.45%	-10.81%	-10.23%	-15.91%	-4.81%
Buyback Yield / Dilution	-39.75%	-39.75%	-17.21%	-67.94%	-1214.82%
Total Shareholder Return	-39.75%	-39.75%	-17.21%	-67.94%	-1214.82%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).